← Open Payments lookup

PAUL ROSSER: Open Payments

NPI 1760596175 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,486 in 136 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,486

Food & beverage: $2,486
CompanyPaymentsAmount
ABBVIE INC.41$701
Takeda Pharmaceuticals U.S.A., Inc.19$380
Janssen Biotech, Inc.15$289
Aimmune Therapeutics, Inc.15$200
Madrigal Pharmaceuticals6$149
Gilead Sciences, Inc.4$106
Ardelyx, Inc.6$105
Celltrion USA Inc.5$98
GENZYME CORPORATION4$88
Phathom Pharmaceuticals, Inc.7$85

Products named: ENTYVIO, RINVOQ, TREMFYA, LINZESS, REZDIFFRA, VOWST, DUPIXENT, IBSRELA.

Industry payments across UT — which companies pay providers there.